Abstract
Graves' disease (GD) is the leading cause of hyperthyroidism, and the majority of GD patients eventually develop disorders of glucose handling, which further affects their quality of life. Yangxin Tongmai formula (YTF) is modified from a famous formula of traditional Chinese medicine for the treatment of cardiovascular diseases. In this study we investigated the potential effects of YTF in the treatment of pediatric GD patients with impaired glucose tolerance. Forty pediatric GD patients and 20 healthy children were recruited for this clinical study. Based on the glucose tolerance, the GD patients were divided into two groups: 20 patients displayed impaired glucose tolerance, while the other 20 patients displayed normal glucose tolerance. YTF was orally administered for 60 days. YTF administration significantly ameliorated the abnormal glucose tolerance and insulin sensitivity in the GD patients with impaired glucose tolerance. To determine the molecular mechanisms of this observation, the number of plasma insulin receptors was determined by ELISA. Before treatment, the fasting and postprandial levels of the insulin receptor were significantly lower in patients with impaired glucose tolerance compared with those in patients with normal glucose tolerance and healthy children. After YTF treatment, both the fasting and the postprandial circulating insulin receptor levels were upregulated, and close to those in healthy children. Therefore, YTF is a potential effective treatment to enhance glucose handling in GD children with impaired glucose tolerance.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Smith TJ, Hegedus L . Graves' Disease. N Engl J Med 2016; 375: 1552–65.
Smith DM, Dutta S, Ahmed F, Thaha MA . Change in practice over four decades in the management of Graves' disease in Scotland. J Thyroid Res 2016; 2016: 9697849.
Doar JW, Stamp TC, Wynn V, Audhya TK . Effects of oral and intravenous glucose loading in thyrotoxicosis. Studies of plasma glucose, free fatty acid, plasma insulin and blood pyruvate levels. Diabetes 1969; 18: 633–9.
Kabadi UM, Eisenstein AB . Impaired pancreatic alpha-cell response in hyperthyroidism. J Clin Endocrinol Metab 1980; 51: 478–82.
Cohen P, Barzilai N, Barzilai D, Karnieli E . Correlation between insulin clearance and insulin responsiveness: studies in normal, obese, hyperthyroid, and Cushing's syndrome patients. Metabolism 1986; 35: 744–9.
Shen DC, Davidson MB, Kuo SW, Sheu WH . Peripheral and hepatic insulin antagonism in hyperthyroidism. J Clin Endocrinol Metab 1988; 66: 565–9.
Ohguni S, Notsu K, Kato Y . Correlation of plasma free thyroxine levels with insulin sensitivity and metabolic clearance rate of insulin in patients with hyperthyroid Graves' disease. Intern Med 1995; 34: 339–41.
Wang Z, Duan DD, Wang YY . Editorial: combination therapy of vascular diseases and fangjiomics: when west meets east in the era of phenomics. Curr Vasc Pharmacol 2015; 13: 420–2.
Duan DD, Wang Z, Zhang BL, Wang YY . Fangjiomics: revealing adaptive omics pharmacological mechanisms of the myriad combination therapies to achieve personalized medicine. Acta Pharmacol Sin 2015; 36: 651–3.
Liu J, Wang Z . Diverse array-designed modes of combination therapies in Fangjiomics. Acta Pharmacol Sin 2015; 36: 680–8.
Wang Z, Liu J, Cheng Y, Wang Y . Fangjiomics: in search of effective and safe combination therapies. J Clin Pharmacol 2011; 51: 1132–51.
Friedman JE, Ishizuka T, Liu S, Farrell CJ, Bedol D, Koletsky RJ, et al. Reduced insulin receptor signaling in the obese spontaneously hypertensive Koletsky rat. Am J Physiol 1997; 273: E1014–23.
Yang ZZ, Liu W, Zhang F, Li Z, Cheng YY . Deciphering the therapeutic mechanisms of Xiao-Ke-An in treatment of type 2 diabetes in mice by a Fangjiomics approach. Acta Pharmacol Sin 2015; 36: 699–707.
Ahren B . Hyperthyroidism and glucose intolerance. Acta Med Scandinav 1986; 22: 5–14.
Levin RJ, Smyth DH . The effect of the thyroid gland on intestinal absorption of hexoses. J Physiol 1963; 169: 755–69.
Hellstrom L, Wahrenberg H, Reynisdottir S, Arner P . Catecholamine-induced adipocyte lipolysis in human hyperthyroidism. J Clin Endocrinol Metab 1997; 82: 159–66.
Vaughan M . An in vitro effect of triiodothyronine on rat adipose tissue. J Clin Invest 1967; 46: 1482–91.
Dimitriadis G, Mitrou P, Lambadiari V, Boutati E, Maratou E, Koukkou E, et al. Glucose and lipid fluxes in the adipose tissue after meal ingestion in hyperthyroidism. J Clin Endocrinol Metab 2006; 91: 1112–8.
Bloomgarden ZT . American Diabetes Association Annual Meeting, 1999: insulin action and the development of type 2 diabetes. Diabetes Care 2000; 23: 248–52.
Huang XP, Yuan ZK, Lu FG, Xie MZ, Hu ZX, Yao XL . Effects of Yangxin Tongmai Tablets on erythrocyte membrane of insulin resistance syndrome. Chin J Information Tradit Chin Med 2003; 10: 12–4
Huang XP, Yuan ZK, Lu FG . Tian Song, Xie MZ, Wang DS, et al. Effects of Yangxin Tongmai Tablet on rythrocyte insulin receptor of insulin resistance syndrome in rats. Chin J Cardiovasc Rev 2004; 2: 220–3.
Hu ZX, Yuan ZK, Huang XP, Lu FG, Xie MZ . An experimental study on Yangxin tongmai tablet to insulin resistance syndrome in rats, hemorheology and insulin sensitivity. Chin J Integr Med Cardio-/Cerebrovasc Dis 2003; 1: 255–7.
Author information
Authors and Affiliations
Corresponding author
Supplementary information
Supplementary Table S1
Baseline parameters of patients in the study GD1 group (DOC 637 kb)
PowerPoint slides
Rights and permissions
About this article
Cite this article
Luo, Yh., Zhu, M., Wang, Dg. et al. Yangxin Tongmai Formula ameliorates impaired glucose tolerance in children with Graves' disease through upregulation of the insulin receptor levels. Acta Pharmacol Sin 39, 923–929 (2018). https://doi.org/10.1038/aps.2017.94
Received:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/aps.2017.94
Keywords
This article is cited by
-
Glycemic variation in uncontrolled Graves’ disease patients with normal glucose metabolism: Assessment by continuous glucose monitoring
Endocrine (2019)
-
New omic and network paradigms for deep understanding of therapeutic mechanisms for Fangji of traditional Chinese medicine
Acta Pharmacologica Sinica (2018)
